arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

LB Pharmaceuticals Inc

LBRX Health Care Biotechnology: Pharmaceutical Preparations
$45.03
Today
as of Aug 5, 16:51 ET
Last 30 days +41.07% Jun 26 → Aug 05
$29.43 $33.62 $37.81 $42.00 $46.19 Jun 26 Jul 06 Jul 14 Jul 21 Jul 29 Aug 05
Open
$28.86
High
$29.56
Low
$28.34
Volume
$155,752
Avg Vol
$256,236
Mkt Cap
$1.2B
P/E (TTM)
—
Beta
—
52w High
$33.47
52w Low
$13.36
Div Yield
—
Shares Out
$29M

Recent Press Releases & News last 60 days · 1 item

Jul 2 · 20:06 Insider Monkey
LB Pharmaceuticals Inc. (LBRX) Maintains Buy Rating as Analyst Highlights LB-102 Potential

Overview

52-week range
$13
$33
100% of range
Avg surprise (last 1)
+10.7%
Avg reaction (last 1)
-4.8%
0% positive
Latest IV / EM
68%
EM ±11.4% · $45 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-39.49$-29.77$-20.05$-10.33$-0.61 Actual $-39.49Actual $-14.79Actual $-0.61Actual $-0.67Est $-0.75 SepMarSepMar/2026
Revenue vs Net Income Revenue Net income
$-28M$-22M$-16M$-10M$-4M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.67 $-0.75 +10.7% — -4.8% earnings
Tue Sep 30, 2025Sep 2025 $-0.61 — — — — financials
Mon Mar 31, 2025Mar 2025 $-14.79 — — — — financials
Mon Sep 30, 2024Sep 2024 $-39.49 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Aug 11, 2026Jun/2026OTHER -$0.84—

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income————————
Net income$-19M—$-4M$-5M$-5M—$-14M$-28M
EPS (diluted)$-0.67—$-0.61—$-14.79—$-39.49—

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$321M$250M$270M——$23M——
Inventory————————
Total current assets$389M$308M$316M——$29M——
Total assets$393M$313M$321M——$34M——
Long-term debt————————
Total liabilities$15M$12M$11M——$14M——
Total equity$379M$301M$310M$-104M$-99M$-95M$-91M$-77M

Implied volatility — last 90 days

61%146%230%314%399% Jun 07 — IV 139% · EM ±19.3%Jun 11 — IV 162% · EM ±17.9%Jun 19 — IV 84% · EM ±18.5%Jun 22 — IV 87% · EM ±18.2%Jun 23 — IV 89% · EM ±18.3%Jun 24 — IV 92% · EM ±18.4%Jun 25 — IV 98% · EM ±19.2%Jun 26 — IV 99% · EM ±19.0%Jun 29 — IV 138% · EM ±24.5%Jun 30 — IV 127% · EM ±21.9%Jul 01 — IV 135% · EM ±22.6%Jul 02 — IV 120% · EM ±19.4%Jul 03 — IV 124% · EM ±19.4%Jul 06 — IV 119% · EM ±16.5%Jul 07 — IV 113% · EM ±14.9%Jul 08 — IV 133% · EM ±16.7%Jul 09 — IV 128% · EM ±15.1%Jul 10 — IV 140% · EM ±15.5%Jul 13 — IV 238% · EM ±19.8%Jul 14 — IV 255% · EM ±18.4%Jul 16 — IV 399% · EM ±16.7%Jul 20 — IV 114% · EM ±26.9%Jul 21 — IV 74% · EM ±17.2%Jul 22 — IV 92% · EM ±21.0%Jul 23 — IV 80% · EM ±18.1%Jul 24 — IV 84% · EM ±18.6%Jul 27 — IV 91% · EM ±19.0%Jul 28 — IV 84% · EM ±17.2%Jul 29 — IV 90% · EM ±17.9%Jul 30 — IV 62% · EM ±12.1%Jul 31 — IV 68% · EM ±13.0%Aug 03 — IV 79% · EM ±14.0%Aug 04 — IV 78% · EM ±13.4%Aug 05 — IV 68% · EM ±11.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in